Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-256011

Chief Financial Officer sold 40,000 shares at $70.00 ($2,800,004)

  • Chief Financial Officer acquired 40,000 shares (option exercise)
  • Chief Financial Officer acquired 1,268 shares (grant or award)
  • Chief Financial Officer gave up 395 shares (to pay taxes)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Mokari Atabak · Chief Financial Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-01 Exercise or conversion : show line 1 in the form 10b5-1 +40,000 $19.26 $770,400 55,257 D
2026-06-01 Sale : show line 2 in the form 10b5-1 −40,000 $70.00 $2,800,004 15,257 D
2026-06-01 Grant or award : show line 3 in the form 10b5-1 +634 $70.44 $44,659 15,891 D
2026-06-01 Grant or award : show line 4 in the form 10b5-1 +634 16,525 D
2026-06-02 Shares withheld for taxes : show line 5 in the form 10b5-1 −395 $70.44 $27,824 16,130 D
Open-market sales · 40,000 sh · avg $70.00 · $2,800,004

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-01 Exercise or conversion : show line 6 in the form 10b5-1 Stock option (right to buy) −40,000 60,000 D
Loading xslF345X06/ownership.xml…